Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
01 June 1992Website:
http://www.steris.comNext earnings report:
07 February 2025Last dividends:
19 November 2024Next dividends:
N/APrice
after hours | Wed, 20 Nov 2024 22:30:01 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
STE Latest News
I am changing my rating for STERIS to 'Buy' with a target price of $240 per share because of the recent drop in stock price and promising growth potential. The company showed a 7.2% increase in organic revenue and a 5.4% rise in adjusted earnings per share, particularly excelling in the Applied Sterilization Technologies area. Even with high interest rates, I expect the biotech sector to slowly recover, which should lead to strong double-digit revenue growth for STERIS' AST division.
On Wednesday, Steris, a company that makes medical equipment, exceeded profit expectations for the second quarter. This was due to ongoing demand for non-urgent medical procedures, which increased sales of its surgical and examination tools.
DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has released its financial results for the second quarter of fiscal 2025, which ended on September 30, 2024. The company reported a 7% rise in total revenue from continuing operations, reaching $1.3 billion, up from $1.2 billion in the same quarter of fiscal 2024. Additionally, the constant currency organic revenue from continuing operations also grew by 7%.
In addition to looking at analysts' estimates for Steris's (STE) revenue and earnings, it's important to assess forecasts for some of its main metrics. This will help us understand how the company may have performed in the quarter that ended in September 2024.
DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will pay a quarterly interim dividend of $0.57 per share. This dividend will be paid on December 19, 2024, to shareholders who are on record as of the end of business on November 19, 2024.
Steris (STE) has the right mix of factors that could lead to a strong earnings report soon. Be ready for the important expectations.
DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will hold a conference call to go over its financial results for the second quarter of fiscal 2025 at 9:00 a.m. ET on November 7, 2024. You can listen to the call live at www.steris-ir.com or by calling 1-833-535-2199 in the U.S. or 1-412-902-6776 internationally and requesting to join the STERIS plc conference call.
Steris (STE) shared its earnings report 30 days ago. What can we expect for the stock moving forward?
STE's positive outlook in the healthcare sector is promising for investors. This suggests that there may be good opportunities for growth and returns. Overall, it looks like a good time for investment in this area.
DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will take part in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, the President and CEO of STERIS, is scheduled to speak at 1:50 p.m. Eastern Time.
What type of business is STERIS?
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
What sector is STERIS in?
STERIS is in the Healthcare sector
What industry is STERIS in?
STERIS is in the Medical Devices industry
What country is STERIS from?
STERIS is headquartered in United States
When did STERIS go public?
STERIS initial public offering (IPO) was on 01 June 1992
What is STERIS website?
https://www.steris.com
Is STERIS in the S&P 500?
Yes, STERIS is included in the S&P 500 index
Is STERIS in the NASDAQ 100?
No, STERIS is not included in the NASDAQ 100 index
Is STERIS in the Dow Jones?
No, STERIS is not included in the Dow Jones index
When was STERIS the previous earnings report?
No data
When does STERIS earnings report?
The next expected earnings date for STERIS is 07 February 2025